Lack of access to medicine is a major driver of drug resistance. How can pharma take action?
10 June 2022
The antibiotic market is unstable, with fragile supply chains and tough market conditions. This report sets out how these factors limit the development of a robust go-to-market model for such products. It features six case studies where companies and their partners are using a combination of access strategies to cut through the complexity and address access at a local level.
Further reading: Access to Medicine Foundation
Author(s): Access to Medicine FoundationEffective Surveillance
Global Ambassador Network
Welcome at the AMR Insights Ambassador Network!
More information and free-of-charge registration
The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).